Preclinical Toxicology Articles & Analysis
2 articles found
These risks can usually be assessed by a combination of downstream purification, HCP residual levels, maximum dose, route of administration, frequency of administration, toxicology data, and clinical data. Although it is generally believed that HCP can potentially trigger an immune response and constitute a clinical safety risk, it is difficult to prove which HCP and ...
In addition, there is currently no unified CMC declaration format for ADC products in the world, and sponsors cannot create globally applicable documents.Monoclonal Antibody (mAb)Regulatory requirements for ADC antibody intermediates and their use as final DS are consistent, and comparable studies between preclinical materials and clinical materials should be conducted in terms ...